公开(公告)号：US20230268071A1

公开(公告)日：2023-08-24

申请号：US18176293

申请日：2023-02-28

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Daniel Milfred Bernstein ,  Martin J. Fennell ,  Mark Kent Sloan ,  Michael Love ,  Lei He ,  Christopher Allen Thomas ,  Udo Hoss ,  Benjamin Jay Feldman ,  Kenneth J. Doniger ,  Gary Ashley Stafford ,  Gary Alan Hayter ,  Phillip Yee ,  Namvar Kiaie ,  Jean-Pierre Cole ,  Marc Barry Taub ,  Louis George Pace ,  Jeffery Mario Sicurello

IPC: G16H40/67 ,  G01N33/487 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1486 ,  A61B5/01 ,  G16H40/63

CPC classification number: G16H40/67 ,  G01N33/48792 ,  A61B5/0017 ,  A61B5/14532 ,  A61B5/1486 ,  A61B5/0022 ,  A61B5/01 ,  A61B5/72 ,  G16H40/63 ,  Y02A90/10 ,  A61B2560/0238

Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.

公开(公告)号：US20230238131A1

公开(公告)日：2023-07-27

申请号：US18130381

申请日：2023-04-03

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Daniel Milfred Bernstein ,  Martin J. Fennell ,  Mark Kent Sloan ,  Michael Love ,  Lei He ,  Christopher Allen Thomas ,  Udo Hoss ,  Benjamin Jay Feldman ,  Kenneth J. Doniger ,  Gary Ashley Stafford ,  Gary Alan Hayter ,  Phillip Yee ,  Namvar Kiaie ,  Jean-Pierre Cole ,  Marc Barry Taub ,  Louis George Pace ,  Jeffery Mario Sicurello

IPC: G16H40/67 ,  G01N33/487 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1486 ,  A61B5/01 ,  G16H40/63

CPC classification number: G16H40/67 ,  G01N33/48792 ,  A61B5/0017 ,  A61B5/14532 ,  A61B5/1486 ,  A61B5/0022 ,  A61B5/01 ,  A61B5/72 ,  G16H40/63 ,  Y02A90/10 ,  A61B2560/0238

Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.

公开(公告)号：US20220240821A1

公开(公告)日：2022-08-04

申请号：US17720947

申请日：2022-04-14

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Wesley Scott Harper ,  Annie C. Tan ,  Timothy Christian Dunn ,  Mark Kent Sloan ,  Kenneth J. Doniger ,  Michael Love ,  Phillip Yee ,  Gary Alan Hayter ,  R. Curtis Jennewine ,  Glenn Howard Berman

IPC: A61B5/145

Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.

公开(公告)号：USD957642S1

公开(公告)日：2022-07-12

申请号：US29776978

申请日：2021-04-01

Applicant: ABBOTT DIABETES CARE INC.

Designer： Christopher Allen Thomas ,  Udo Hoss ,  Martin J. Fennell ,  Lei He ,  Michael Love ,  Phillip Yee

公开(公告)号：USD955599S1

公开(公告)日：2022-06-21

申请号：US29776977

申请日：2021-04-01

Applicant: ABBOTT DIABETES CARE INC.

Designer： Christopher Allen Thomas ,  Udo Hoss ,  Martin J. Fennell ,  Lei He ,  Michael Love ,  Phillip Yee

公开(公告)号：US20220125358A1

公开(公告)日：2022-04-28

申请号：US17362529

申请日：2021-06-29

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Samuel M. Curry ,  Manuel L. Donnay ,  Tuan Nguyen ,  Louis G. Pace ,  Peter G. Robinson ,  Phillip Yee

IPC: A61B5/15 ,  A61B5/151 ,  A61B5/145 ,  A61B5/00 ,  A61M5/158 ,  A61B5/157 ,  A61B17/34

Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided, as well as methods of inserting medical devices.

公开(公告)号：US20220110560A1

公开(公告)日：2022-04-14

申请号：US17561414

申请日：2021-12-23

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Phillip Yee ,  Christopher A. Thomas ,  Udo Hoss ,  Lei He ,  Michael R. Love

IPC: A61B5/1486 ,  A61B5/00 ,  A61B5/0205 ,  A61M5/172 ,  G06K7/10 ,  A61B5/145 ,  A61M5/158 ,  C12Q1/00 ,  H04L67/12 ,  A61M5/32

Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.

公开(公告)号：US11166656B2

公开(公告)日：2021-11-09

申请号：US17137664

申请日：2020-12-30

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Phillip Yee ,  Christopher A. Thomas ,  Udo Hoss ,  Lei He ,  Michael R. Love

IPC: A61B5/00 ,  A61B5/1486 ,  A61B5/0205 ,  G06K7/10 ,  A61B5/145 ,  A61M5/158 ,  C12Q1/00 ,  H04L29/08 ,  A61M5/172 ,  A61M5/32

Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.

公开(公告)号：US11006872B2

公开(公告)日：2021-05-18

申请号：US17033588

申请日：2020-09-25

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Phillip Yee ,  Christopher A. Thomas ,  Udo Hoss ,  Lei He ,  Michael R. Love

IPC: A61B5/00 ,  A61B5/1486 ,  A61B5/0205 ,  G06K7/10 ,  A61B5/145 ,  A61M5/158 ,  C12Q1/00 ,  H04L29/08 ,  A61M5/172 ,  A61M5/32

Abstract: An apparatus for insertion of a medical device in the skin of a subject is provided.

公开(公告)号：US10918342B1

公开(公告)日：2021-02-16

申请号：US17067443

申请日：2020-10-09

Applicant: ABBOTT DIABETES CARE INC.

Inventor： Wesley Scott Harper ,  Annie C. Tan ,  Timothy Christian Dunn ,  Mark Kent Sloan ,  Kenneth J. Doniger ,  Michael Love ,  Phillip Yee ,  Gary Alan Hayter ,  R. Curtis Jennewine ,  Glenn Howard Berman

IPC: A61B5/00 ,  A61B5/145 ,  G16H40/63 ,  G16H20/17

Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.